• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ: ADMA )

17.40 -0.50 (-2.79%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
January 08, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
December 18, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
December 12, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Adma Biologics Stock Crushed the Market on Friday
November 17, 2023
The network of FDA-approved collection facilities continues to grow. 
Via The Motley Fool
Earnings Preview: ADMA Biologics
November 07, 2023
Via Benzinga
Preview: ADMA Biologics's Earnings
August 08, 2023
Via Benzinga
Recap: ADMA Biologics Q1 Earnings
May 10, 2023
Via Benzinga
A Preview Of ADMA Biologics's Earnings
May 09, 2023
Via Benzinga
Earnings Outlook For ADMA Biologics
March 22, 2023
Via Benzinga
ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD
November 16, 2023
FDA Approval Signifies the Accomplishment of ADMA’s Corporate Goal of Plasma Supply Self-Sufficiency 
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Adma Biologics Was Trouncing the Market Today
November 09, 2023
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 08, 2023
Via Benzinga
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
November 08, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
November 01, 2023
Conference Call Scheduled for November 8, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Shares of ADMA Biologics Are Climbing Thursday
August 10, 2023
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed. 
Via The Motley Fool
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
August 09, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
August 02, 2023
Conference Call Scheduled for August 9, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
July 19, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
July 19, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
May 03, 2023
Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics Announces Amendment to Credit Agreement
May 02, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
March 24, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dow Down 150 Points; US Durable Goods Orders Drop In February
March 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.50% to 31,944.01 while the NASDAQ fell 0.52%... 
Via Benzinga
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
March 24, 2023
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
March 23, 2023
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported  
Via Benzinga
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 23, 2023
From ADMA Biologics, Inc.
Via GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
March 16, 2023
Conference Call Scheduled for March 23, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap